Cell membrane cation transport systems during aldosterone antagonism

Area of Science:

• Cardiovascular Pharmacology
• Renal Physiology
• Cellular Physiology

Background:

• Aldosterone antagonists, like spironolactone, are used to manage hypertension.
• The precise mechanisms by which spironolactone affects intracellular cation concentrations and transport remain under investigation.

Purpose of the Study:

• To investigate the effects of spironolactone on blood pressure, intracellular cation concentrations, and cation transport systems in healthy male subjects.
• To elucidate the relationship between spironolactone's blood pressure-lowering effects and changes in cellular ion homeostasis.

Main Methods:

• A double-blind, placebo-controlled parallel study was conducted over 1 week.
• Subjects received either placebo or 100 mg spironolactone daily.
• Measurements included blood pressure, intracellular cationic concentrations (Na+, Ca2+, K+, Mg2+), and transmembrane cation transport system activity.

Main Results:

• Spironolactone significantly decreased standing systolic blood pressure compared to placebo (p < 0.001).
• No significant changes were observed in standing diastolic blood pressure.
• Spironolactone treatment led to decreased intraerythrocyte and intraplatelet Na+ and free Ca2+ concentrations.
• Platelet Na+-pump activity was reduced, while erythrocyte Na+, Li(+)-countertransporter, Na+, K(+)-cotransporter, and cation leakage remained unchanged.

Conclusions:

• Spironolactone's blood pressure-lowering effect in men is associated with reduced cytosolic free platelet Ca2+ concentration.
• The study demonstrates a reduction in intraplatelet and intraerythrocyte Na+ concentration and platelet Na+ pump activity.
• These findings suggest that spironolactone influences cellular cation balance, contributing to its antihypertensive action.